The incidence of different pellet size on growth, gut evacuation, feed digestibility and feed waste in gilthead sea bream (Sparus aurata)

The feeding behaviour of gilthead sea bream (Sparus aurata) consists in cracking and chewing feed. In farming condition, this results in crushing feed pellets with an occasional loss of some fragments which can vary in response to pellet dimension, thus affecting feed waste at the on-growing stage. However, few studies have addressed this issue and even less information on the further effect of different pellet size on growth, gut evacuation and feed efficiency are available on this species. Thus, a 122-day study was undertaken to assess the effects of three pellet size (2 mm, S; 4 mm, M and 6 mm, L) on growth, gut evacuation, feed waste and feed digestibility during the on-growing of gilthead sea bream (initial weight: 215.9 +/- 1.8 g). No significant effects of pellet size on growth (final body weight and SGR) were observed. Pellets diameters had no effects on feed digestibility (protein and dry matter) and feed efficiency parameters (FCR, PER, GPE, GLE) even if differences in the gastric evacuation rate were detected at different pellet size. At this regard, the shape-rate model developed to estimate the gastrointestinal evacuation pattern, evidenced a slower gastric evacuation rate in the 6 mm diet, while no differences in foregut evacuation rate were observed. Data on feed waste, highlighted how feed losses by chewing was practically absent in the S (2 mm) diet while in the M (4 mm) and L (6 mm) diets 24.3 and 17.3% of the entire meal was losses by chewing activity, respectively. The study reinforces previous observation that feeding pellets size of 4 and 6 mm in gilthead sea bream within 200-450 g could induced an excess of feed waste by chewing activity with economic and environmental implication. Despite the reduced feed intake observed, pellets size of 2 mm did not lead to any feed losses by chewing and was able to guarantee similar growth compared to the other diets. Further studies considering intermediate pellets size (3 mm) may be useful in order to further optimize the pellet size choice during the on-growing phase of this species

Effects of Bioactive Peptides from Atlantic Salmon Processing By-Products on Oxyntopeptic and Enteroendocrine Cells of the Gastric Mucosa of European Seabass and Gilthead Seabream

The present study was designed to evaluate the effects of dietary levels of bioactive peptides (BPs) derived from salmon processing by-products on the presence and distribution of peptic cells (oxyntopeptic cells, OPs) and enteric endocrine cells (EECs) that contain GHR, NPY and SOM in the gastric mucosa of European seabass and gilthead seabream. In this study, 27 seabass and 27 seabreams were divided into three experimental groups: a control group (CTR) fed a control diet and two groups fed different levels of BP to replace fishmeal: 5% BP (BP5%) and 10% BP (BP10%). The stomach of each fish was sampled and processed for immunohistochemistry. Some SOM, NPY and GHR-IR cells exhibited alternating “open type” and “closed type” EECs morphologies. The BP10% group (16.8 ± 7.5) showed an increase in the number of NPY-IR cells compared to CTR (CTR 8.5 ± 4.8) and BP5% (BP10% vs. CTR p ≤ 0.01; BP10% vs. BP5% p ≤ 0.05) in the seabream gastric mucosa. In addition, in seabream gastric tissue, SOM-IR cells in the BP 10% diet (16.8 ± 3.5) were different from those in CTR (12.5 ± 5) (CTR vs. BP 10% p ≤ 0.05) and BP 5% (12.9 ± 2.5) (BP 5% vs. BP 10% p ≤ 0.01). EEC SOM-IR cells increased at 10% BP (5.3 ± 0.7) compared to 5% BP (4.4 ± 0.8) (5% BP vs. 10% BP p ≤ 0.05) in seabass. The results obtained may provide a good basis for a better understanding of the potential of salmon BPs as feed ingredients for seabass and seabream.publishedVersio

Prescription appropriateness of anti-diabetes drugs in elderly patients hospitalized in a clinical setting: evidence from the REPOSI Register

Diabetes is an increasing global health burden with the highest prevalence (24.0%) observed in elderly people. Older diabetic adults have a greater risk of hospitalization and several geriatric syndromes than older nondiabetic adults. For these conditions, special care is required in prescribing therapies including anti- diabetes drugs. Aim of this study was to evaluate the appropriateness and the adherence to safety recommendations in the prescriptions of glucose-lowering drugs in hospitalized elderly patients with diabetes. Data for this cross-sectional study were obtained from the REgistro POliterapie-Società Italiana Medicina Interna (REPOSI) that collected clinical information on patients aged ≥ 65 years acutely admitted to Italian internal medicine and geriatric non-intensive care units (ICU) from 2010 up to 2019. Prescription appropriateness was assessed according to the 2019 AGS Beers Criteria and anti-diabetes drug data sheets.Among 5349 patients, 1624 (30.3%) had diagnosis of type 2 diabetes. At admission, 37.7% of diabetic patients received treatment with metformin, 37.3% insulin therapy, 16.4% sulfonylureas, and 11.4% glinides. Surprisingly, only 3.1% of diabetic patients were treated with new classes of anti- diabetes drugs. According to prescription criteria, at admission 15.4% of patients treated with metformin and 2.6% with sulfonylureas received inappropriately these treatments. At discharge, the inappropriateness of metformin therapy decreased (10.2%, P < 0.0001). According to Beers criteria, the inappropriate prescriptions of sulfonylureas raised to 29% both at admission and at discharge. This study shows a poor adherence to current guidelines on diabetes management in hospitalized elderly people with a high prevalence of inappropriate use of sulfonylureas according to the Beers criteria

Effect of Essential Oils on the Oxyntopeptic Cells and Somatostatin and Ghrelin Immunoreactive Cells in the European Sea Bass (Dicentrarchus labrax) Gastric Mucosa

The current work was designed to assess the effect of feed supplemented with essential oils (EOs) on the histological features in sea bass’s gastric mucosa. Fish were fed three diets: control diet (CTR), HERBAL MIX® made with natural EOs (N-EOs), or HERBAL MIX® made with artificial EOs obtained by synthesis (S-EOs) during a 117-day feeding trial. Thereafter, the oxyntopeptic cells (OPs) and the ghrelin (GHR) and somatostatin (SOM) enteroendocrine cells (EECs) in the gastric mucosa were evaluated. The Na+K+-ATPase antibody was used to label OPs, while, for the EECs, anti-SOM and anti-GHR antibody were used. The highest density of OP immunoreactive (IR) area was in the CTR group (0.66 mm2 ± 0.1). The OP-IR area was reduced in the N-EO diet group (0.22 mm2 ± 1; CTR vs. N-EOs, p < 0.005), while in the S-EO diet group (0.39 mm2 ± 1) a trend was observed. We observed an increase of the number of SOM-IR cells in the N-EO diet (15.6 ± 4.2) compared to that in the CTR (11.8 ± 3.7) (N-EOs vs. CTR; p < 0.05), but not in the S-EOs diet. These observations will provide a basis to advance current knowledge on the anatomy and digestive physiology of this species in relation to pro-heath feeds

Effects of different feeding frequencies on growth, feed utilisation, digestive enzyme activities and plasma biochemistry of gilthead sea bream (Sparus aurata) fed with different fishmeal and fish oil dietary levels

In the context of Mediterranean aquaculture many efforts have been made in terms of reducing marine-derived ingredients in aquafeed formulation. On the other hand, little attention has been paid to the manipulation of feeding frequency at the on-growing phase, where the high costs related to feeding procedures and the optimisation of feed efficiency and fish health are key aspects for the economic and environmental sustainability of the production cycle. The effects of different feeding frequencies (F) (1F) one meal day−1, (2F) two meals day−1, (3F) three meals day−1 on growth, digestive enzyme activity, feed digestibility and plasma biochemistry were studied in gilthead sea bream (Sparus aurata, L. 1758) fed with high (FM30/FO15, 30% fishmeal FM, 15% fish oil, FO) and low (FM10/FO3; 10% FM and 3% FO) FM and FO levels. Isonitrogenous and isolipidic extruded diets were fed to triplicate fish groups (initial weight: 88.3 ± 2.4 g) by a fixed ration over 109 days. No significant effects of feeding frequency on overall performance, feed efficiency and feed digestibility during the on-growing of gilthead sea bream fed high or low fishmeal and fish oil dietary level were observed. Pepsin activity showed an apparent decrease in fish receiving more than one meal a day which was not compensated by an increased production of alkaline proteases (either trypsin or chymotrypsin), particularly in fish fed on low FM. Although there were no effects on growth and feed utilisation at increasing feeding frequency, trypsin decreased significantly with an increasing number of meals only under low FMFO diet. Thus, it seemed that consecutive meals could have amplified the potential trypsin inhibitor effect of the vegetable meal-based diet adopted. Most of the plasma parameters related to nutritional and physiological conditions were not affected by feeding frequency, however an effect on electrolytes (Na+, Cl), cortisol and creatinine was observed. The higher level of plasma creatinine detected in fish fed a single daily meal with high FMFO level seems to be within physiological values in relation to the higher protein efficiency observed with this diet. However, it will require further attention to exclude a possible overload of kidney functionality. According to the results, gilthead sea bream seems able to maximize feed utilisation regardless of the number of meals, and this could be a useful indicator for planning feeding activity at farm level to optimise growth of fish and costs of feeding procedures.This research was undertaken under the MedAID (Mediterranean Aquaculture Integrated Development) project, which has received funding from the European Union's Horizon 2020 Research and Innovation Programme, Call H2020-SFS-23-2016, Grant agreement no 727315 (http://www.medaid-h2020.eu/).Peer reviewe

Impact of natural Neuromedin-B receptor variants on iron metabolism

Iron overload heritability remains partly unexplained. By performing whole exome sequencing in three patients with clinical phenotype of hemochromatosis not accounted by known genetic risk factors, we identified in all patients rare variants predicted to alter activity of Neuromedin-B receptor (NMBR). Coding NMBR mutations were enriched in 129 patients with hereditary hemochromatosis or iron overload phenotype, as compared to ethnically matched controls including 100 local healthy blood donors and 1000Genomes project participants (15.5% vs 5%, p=0.0038 at burden test), and were associated with higher transferrin saturation in regular blood donors (p=0.04). Consistently, in 191 patients with nonalcoholic fatty liver, the most common low-frequency p.L390M variant was independently associated with higher ferritin (p=0.03). In 58 individuals, who underwent oral iron challenge, carriage of the p.L390M variant was associated with higher transferrin saturation and lower hepcidin release. Furthermore, the circulating concentration of the natural NMBR ligand, Neuromedin-B, was reduced in response to iron challenge, and was decreased in individuals carrying the p.L390M variant and with hemochromatosis in parallel with increased transferrin saturation. In mice, Nmbr was induced by chronic dietary iron overload in the liver, gut, pancreas, spleen, and skeletal muscle, while Nmb was downregulated in the gut, pancreas and the spleen. Finally, Nmb amplified holo-transferrin dependent induction of hepcidin in primary mouse hepatocytes, which was abolished by the NMBR antagonist PD168368.Conclusions: NMBR natural variants were enriched in patients with iron overload and associated with facilitated iron absorption possibly related to a defect of iron-induced hepcidin release. This article is protected by copyright. All rights reserved

Interaction between dietary composition and seasonal temperature changes in gilthead sea bream Sparus aurata: effects on growth, fat deposition, plasma biochemistry, digestive enzyme activity and gut bacterial community

Trabajo presentado en Aquaculture Europe 19 (Our future, growing from water), celebrado en Berlín del 7 al 10 de octubre de 2019.The optimization of feeding strategy in relation to the environmental condition needs further investigation in order to maximise performance, fish health and fish quality of Mediterranean farmed species. Environmental temperature during seasonal changes may affects fish metabolism, digestive enzymes activity and gut bacterial community which may exert an effect on performance and tissue composition (Couto et al., 2012; Guerreiro et al., 2016). Data relating interaction between different dietary protein and energy ratio and water temperature changes on digestion condition, gut bacterial community and fat deposition of gilthead seabream fed current aquafeed formulations are scarce. For this reason, the purpose of this study was to evaluate the effects of two dietary protein and dietary energy ratio (DP/DE) during temperature changes on growth, feed efficienc , fat deposition, plasma biochemistry, digestive enzyme activity and gut bacterial community of gilthead sea bream (Sparus aurata).This research was supported by ERC (European Research Council) in MedAID project (Mediterranean Aquaculture Integrated Development), Call H2020-SFS-2016-2017 (Sustainable Food Security – Resilient and resource-efficient value chains), Grant Agreement n. 727315.Peer reviewe

Clinical characteristics and outcomes of vaccinated patients hospitalised with SARS-CoV-2 breakthrough infection: Multi-IPV, a multicentre study in Northern Italy

Background: Despite the well-known efficacy of anti-COVID-19 vaccines in preventing morbidity and mortality, several vaccinated individuals are diagnosed with SARS-CoV-2 breakthrough infection, which might require hospitalisation. This multicentre, observational, and retrospective study aimed to investigate the clinical characteristics and outcomes of vaccinated vs. non-vaccinated patients, both hospitalised with SARS-CoV-2 infection in 3 major hospitals in Northern Italy. Methods: Data collection was retrospective, and paper and electronic medical records of adult patients with a diagnosed SARS-CoV-2 infection were pseudo-anonymised and analysed. Vaccinated and non-vaccinated individuals were manually paired, using a predetermined matching criterion (similar age, gender, and date of hospitalisation). Demographic, clinical, treatment, and outcome data were compared between groups differing by vaccination status using Pearson’s Chi-square and Mann-Whitney tests. Moreover, multiple logistic regression analyses were performed to assess the impact of vaccination status on ICU admission or intra-hospital mortality. Results: Data from 360 patients were collected. Vaccinated patients presented with a higher prevalence of relevant comorbidities, like kidney replacement therapy or haematological malignancy, despite a milder clinical presentation at the first evaluation. Non-vaccinated patients required intensive care more often than their vaccinated counterparts (8.8% vs. 1.7%, p = 0.002). Contrariwise, no difference in intra-hospital mortality was observed between the two groups (19% vs. 20%, p = 0.853). These results were confirmed by multivariable logistic regressions, which showed that vaccination was significantly associated with decreased risk of ICU admission (aOR=0.172, 95%CI: 0.039–0.542, p = 0.007), but not of intra-hospital mortality (aOR=0.996, 95%CI: 0.582–1.703, p = 0.987). Conclusions: This study provides real-world data on vaccinated patients hospitalised with COVID-19 in Northern Italy. Our results suggest that COVID-19 vaccination has a protective role in individuals with higher risk profiles, especially regarding the need for ICU admission. These findings contribute to our understanding of SARS-CoV-2 infection outcomes among vaccinated individuals and emphasise the importance of vaccination in preventing severe disease, particularly in those countries with lower first-booster uptake rates

Correction to: Prescription appropriateness of anti-diabetes drugs in elderly patients hospitalized in a clinical setting: evidence from the REPOSI Register

No abstract availabl